Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

3.07USD
13 Jul 2018
Change (% chg)

$0.14 (+4.78%)
Prev Close
$2.93
Open
$2.95
Day's High
$3.10
Day's Low
$2.92
Volume
29,297
Avg. Vol
6,072
52-wk High
$5.46
52-wk Low
$0.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.442
Dec 0.00 -0.377
FY 2017 Sep '17 0.00 -0.448
Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
FY 2016 Sep '16 0.00 -0.530
Jun '16 0.00 -0.746
Mar '16 0.00 -0.350
Dec 0.00 -0.532
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Sep-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.32 -0.32 -0.32 --
Quarter Ending Sep-18 1 -0.14 -0.14 -0.14 --
Year Ending Sep-18 2 -1.42 -1.28 -1.57 --
Year Ending Sep-19 1 -0.54 -0.54 -0.54 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta -- 0.90 0.89
Price to Sales (TTM) -- 3.94 5.73
Price to Book (MRQ) 1.38 4.88 5.45
Price to Tangible Book (MRQ) -- 5.70 7.05
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions -- 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.28 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.47 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 0.90 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 0.06 2.94 3.03
LT Debt to Equity (MRQ) 0.00 10.03 12.39
Total Debt to Equity (MRQ) 46.72 14.07 16.72
Interest Coverage (TTM) -3.13 35.78 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.72 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.50 10.81
Operating Margin (TTM) -- 14.31 4.57
Operating Margin - 5 Yr. Avg. -- 14.45 6.23
Pre-Tax Margin (TTM) -- 14.80 5.43
Pre-Tax Margin - 5 Yr. Avg. -- 14.86 6.67
Net Profit Margin (TTM) -- 11.05 1.73
Net Profit Margin - 5 Yr. Avg. -- 11.16 2.94
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,055,720 860,414,722
Net Income/Employee (TTM) -- 112,126,542 101,211,891
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.00 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.55 11.58 11.14
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -66.76 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.14
Return on Equity (TTM) -66.76 16.60 16.34
Return on Equity - 5 Yr. Avg. -- 17.97 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -67.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.57%
# of Holders: 7
Total Shares Held: 701,047
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.